Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chang, Xia, Bai-Rong, Zhang, Zhao-Cong, Zhang, Yong-Jian, Lou, Ge, Jin, Wei-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572849/
https://www.ncbi.nlm.nih.gov/pubmed/33123161
http://dx.doi.org/10.3389/fimmu.2020.577869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572849/
https://www.ncbi.nlm.nih.gov/pubmed/33123161
http://dx.doi.org/10.3389/fimmu.2020.577869

Ejemplares similares